Skip to Content
 

News: Research

A critical factor for wound healing

Friday, July 19th, 2019

Vanderbilt-Ingram Cancer Center scientists have discovered a role for a tumor suppressor protein in skin wound healing.

Center for Immunobiology grows, bolsters program

Friday, July 19th, 2019

The Vanderbilt Center for Immunobiology has relaunched its mission with a greater focus on human immunology, an endeavor supported by additional researchers, more funding support and designation as a Center of Excellence.

Vanderbilt team shows how stomach bug can trigger cancer

Thursday, July 11th, 2019

Researchers have obtained the first high-resolution image of a molecular “machine” used by the insidious stomach bug Helicobacter pylori to inject a cancer-causing protein into the stomach lining.

Clinical study tests drug that may prevent cancer metastasis

Thursday, July 11th, 2019

A clinical study of a drug that may block cancer metastasis is currently enrolling patients at the Vanderbilt-Ingram Cancer Center.

Study identifies critical regulator of tumor-specific T cell differentiation

Saturday, June 29th, 2019

A study published June 17 in Nature offers clues as to why blocking inhibitory receptors on tumor-infiltrating T cells may not always work

Potential probe for early ovarian cancer

Saturday, June 29th, 2019

Larry Marnett and colleagues have developed what may become the first agent for targeted PET imaging of cancer tissues, such as ovarian cancer, that express high levels of the COX-1 enzyme.

Fish oil and cancer prevention

Saturday, June 29th, 2019

Fish oil supplementation provides a modest but beneficial effect on reducing molecules associated with colorectal cancer development.

Steroid binding to metabolic enzyme

Saturday, June 29th, 2019

Understanding how a steroid-metabolizing enzyme binds to its substrates may aid in designing drugs to treat sexual dysfunction as well as prostate cancer.

Cardiac toxicity risk factors identified with relapsed multiple myeloma therapy

Saturday, June 29th, 2019

More than half of patients with relapsed multiple myeloma treated with carfilzomib experienced cardiac issues during treatment, according to a multi-institutional study published June 12 in the Journal of Clinical Oncology.

Biomarkers of DNA methylation can be a predictor of breast cancer risk

Saturday, June 29th, 2019

Biomarkers of DNA methylation, which regulate gene expression, can be a predictor of breast cancer risk, according to a study published in Journal of the National Cancer Institute.

Next Page »